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Summary 
The Norwegian Scientific Committee for Food and Environment (Vitenskapskomiteen for mat 
og miljø, VKM) has, at the request of the Norwegian Food Safety Authority (Mattilsynet; 
NFSA), evaluated the intake of chromium. VKM has also conducted scenario calculations to 
illustrate the consequences of establishing maximum limit for chromium at 50, 125, 200 or 
300 µg/day in food supplements. The former maximum limit for chromium of 125 µg/day in 
food supplements was revoked 30 May 2017. 
Chromium is present in food and supplements mainly as trivalent chromium, Cr(III), whereas 
in drinking water, chromium is present mainly as Cr(VI). Trivalent chromium has been 
reported to be an essential trace element in that it has been postulated to be necessary for 
the efficacy of insulin in regulation of the metabolism of carbohydrates, lipids and proteins. 
However, no mechanisms for these roles have been identified. Absorption of Cr(III) from 
food has been estimated to range from 0.4 to 2.5%, depending among other factors on the 
chemical properties of the ingested source and the presence of other dietary components. 
Absorption efficiency of supplemental Cr(III) has been reported to be between 0.1 and 
5.2%, and to vary between the chromium complex ingested. 
In general, Cr(III) has very low toxicity by the oral route (ATSDR, 2012), and there are 
hardly any well-documented observations of toxicity after peroral intake in humans. In a 
series of animal repeat dose toxicity studies, the no observed adverse effect level (NOAEL) 
for general toxicity was consistently the highest dose tested (EFSA, 2014b). 
Chromium is ubiquitous in foods, and rich sources include meat and meat products, oils and 
fats, breads and cereals, fish, pulses and spices. 
There are no Norwegian recommendations for intake of chromium. The Nordic Nutrition 
Recommendations and the European Food Safety Authority (EFSA) concluded that no 
recommendations could be given for chromium due to lack of sufficient evidence (EFSA, 
2014a; NNR Project Group, 2012). Furthermore, no tolerable upper intake levels (UL) have 
been established for chromium. However, the EFSA Panel on Contaminants in the Food 
Chain (CONTAM Panel) suggested a tolerable daily intake (TDI) at 300 µg trivalent chromium 
per kg bodyweight per day based on a NOAEL in a rat study and an uncertainty factor at 
1000. Due to uncertainty in the available data on developmental and reproduction toxicity, 
the EFSA Panel applied an uncertainty factor of 10 in addition to the default uncertainty 
factor of 100 for the extrapolations from rodents to humans and for human variability. 
The chromium intake in Norway is not known, since Norwegian food composition data are 
not available. VKM has therefore based this evaluation upon intake data from EFSA. Values 
from EFSA are likely to be valid also for Norway. Median dietary chromium intakes were 28.6 
-44.0 μg/day (medians of lower and upper bound) in the category toddlers (1 to < 3 years), 
55.4-76.2 μg/day in other children (3 to < 10 years), 52.1-69.4 μg/day in adolescents (≥10 
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to <14 years), 73.6-98.1 in adolescents (≥14 to <18 years) and 63.0-84.0 μg/day in adults 
(18-65 years) (EFSA, 2014b). These values are 80-300 times lower than the suggested 
tolerable daily intake (TDI). 
To illustrate the consequences of amending maximum limits for chromium to 50, 125, 200 or 
300 μg per daily dose in food supplements, VKM has compared these levels and various 
intakes from food to the TDI at 300 µg/kg bw per day.  
Even with the highest level of supplemental intake and additional median levels as well as 
the 95 percentile intakes from food, the estimated exposure will be 16-48 times lower than  
the TDI of 300 µg/kg bw per day in all age groups except for the 95th percentile intake in 
toddlers, where it will be about nine times lower. 
VKM emphasises that the current assessment of maximum limits for Cr(III) in food 
supplements is merely based on published reports concerning upper levels from the WHO 
(1996), IOM (2001, USA), SCF (2003, EU), EVM (2003, UK) , NNR (2012, Nordic countries), 
and EFSA (2014b). VKM has not conducted any systematic review of the literature for the 
current opinion, as this was outside the scope of the terms of reference from NFSA. 
Key words: VKM, risk assessment, Norwegian Scientific Committee for Food and 
Environment, chromium, food supplement, upper level, exposure. 
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Sammendrag på norsk 
Vitenskapskomiteen for mat og miljø (VKM) har vurdert inntaket av krom i befolkningen på 
oppdrag fra Mattilsynet. VKM har også gjort scenarioberegninger for å illustrere 
konsekvensene av å endre maksimumsgrensen for krom i kosttilskudd til 50, 125, 200 eller 
300 µg/dag. Tidligere maksimumsgrense var 125 µg/dag. Den ble opphevet 30. mai 2017. 
I mat og kosttilskudd forekommer krom hovedsakelig som trivalent krom, Cr(III), mens 
seksvalent krom, Cr(VI), er den vesentligste formen i drikkevann. Trivalent krom har blitt 
rapportert å være et essensielt sporstoff ved at det har blitt hevdet å være nødvendig for 
insulinets effektivitet i regulering av metabolismen av karbohydrater, fett og proteiner. 
Mekanismen for denne rollen er imidlertid ikke kjent. Absorbsjon av Cr(III) fra mat kan 
variere fra 0,4 til 2,5 %, avhengig av blant annet av matvarenes kjemiske egenskaper og av 
andre komponenter i kosten. Absorpsjon av Cr (III) fra kosttilskudd er rapportert å være 
mellom 0,1 og 5,2 %, avhengig av kromforbindelsen. 
Generelt er oralt Cr(III) lite toksisk (ATSDR, 2012), og det er knapt noen veldokumenterte 
observasjoner av toksiske effekter etter peroral inntak hos mennesker. I en serie 
toksisitetsstudier med gjentatte doser i mus og rotter, var no observed adverse effect level, 
NOAEL - dvs. høyeste daglige dose i mg/kg kroppsvekt som ikke ga negative helseffekter, 
konsekvent den høyeste dosen som ble testet (EFSA, 2014b). 
Krom finnes i mange matvarer. Rike kilder inkluderer kjøtt og kjøttprodukter, fett og oljer, 
brød og andre kornprodukter, fisk, belgvekster og krydder. 
Det er ikke gitt norske anbefalinger for inntak av krom. De nordiske 
næringsstoffanbefalingene og European Food Safety Authority (EFSA) konkluderte også med 
at det ikke er tilstrekkelig data til å gi næringsstoffanbefalinger for inntak av krom (EFSA, 
2014a; NNR Project Group, 2012). Det er heller ikke fastsatt øvre tolerable inntaksnivåer 
(UL) for krom. EFSA-panelet for forurensninger i matvarer (CONTAM-panelet) foreslo 
imidlertid et tolerabelt daglig inntak (TDI) på 300 μg trivalent krom per kg kroppsvekt per 
dag basert NOAEL i en rottestudie og en usikkerhetsfaktor på 1000. På grunn av usikkerhet i 
dataene for utviklings- og reproduksjonstoksisitet, brukte EFSA-panelet en ekstra 
usikkerhetsfaktor på 10 i tillegg til standard usikkerhetsfaktoren på 100 for ekstrapoleringen 
fra gnagere til mennesker og for menneskelig variabilitet. 
Inntak av krom fra kosten i Norge er ikke kjent ettersom det ikke finnes informasjon om 
innholdet av krom i den norske Matvaretabellen. VKM har derfor basert denne vurderingen 
på inntaksdata fra EFSA. Inntaksdataene fra EFSA vil trolig også være representative for 
norske forhold. I små barn, 1 til <3 år, var mediant inntak av krom fra kosten 28,6-
44,0 μg/dag (medianer av lower bound og upper bound konsentrasjoner) i eldre barn, 3 til 
<10 år, var inntaket 55,4-76.2 μg/dag. I ungdom, ≥10 til <14 år, var inntaket av krom 52,1-
69,4 μg/dag, og i ungdom, ≥14 til <18 år, var inntaket av krom 73,6-98,1, mens inntaket 
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blant voksne, 18-65 år, var 63,0-84,0 μg/dag (EFSA, 2014b). Disse inntaksnivåene er 80-300 
ganger lavere enn det foreslåtte tolerable daglige inntaket (TDI). 
For å illustrere konsekvensene av å endre maksimumsgrenser for krom til 50, 125, 200 eller 
300 μg per daglig dose i kosttilskudd, har VKM lagt de ulike inntakene fra kosten til disse 
foreslåtte maksimumsgrensene og sammenlignet med det tolerable daglige inntaket (TDI) på 
300 μg/kg kroppsvekt per dag. 
Selv med den høyeste foreslåtte maksimumsgrensen i kosttilskudd vil krominntaket være 16-
48 ganger lavere enn det tolerable daglig inntaket på 300 µg/kg kroppsvekt per dag i alle 
aldersgrupper unntatt de minste barna når vil legger til både mediant krominntak og inntak i 
95-persentilen fra kosten. Hos de minste barna, 1 til <3 år, vil inntaket da være om lag ni 
ganger lavere enn tolerabelt daglig inntak. 
VKM presiserer at denne vurderingen av maksimumsgrenser for krom i kosttilskudd er basert 
på publiserte rapporter om øvre inntaksnivåer fra WHO (1996), IOM (2001, USA), SCF (2003, 
EU), EVM (2003, Storbritannia), NNR (2012, de nordiske landene) og EFSA (2014b). 
Ettersom mandatet i bestillingen fra Mattilsynet var å vurdere øvre inntaksnivå basert på 
allerede eksisterende rapporter, har VKM ikke gjennomført et eget systematisk litteratursøk 
for å vurdere det samlede kunnskapsgrunnlaget i denne vurderingen. 
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Abbreviations and/or glossary 
Abbreviations 
AI – adequate intake 
AOAC – Association of Analytical Communities, an independent international    
standardization agency 
ANS – Panel in EFSA on Food Additives and Nutrient Sources Added to Food 
AR – average requirement 
bw  – body weight 
CI  – confidence interval  
CONTAM – Panel in EFSA on Contaminants in the Food Chain 
DRI  – dietary reference intake 
DRV  – dietary reference value 
EAR  – estimated average requirement (IOM).  
EFSA  – European Food Safety Authority 
EVM  – Expert group on vitamins and minerals of the Food Standard Agency, UK 
GSH  – reduced glutathion 
GSSG  – oxidised glutathion 
IOM  – Institute of Medicine, USA 
IU  – international unit 
LB  – lower bound 
LOAEL  – lowest observed adverse effect level 
MOE  – margin of exposure 
NDA  – Panel in EFSA on Dietetic Products, Nutrition and Allergies 
NFSA  – Norwegian Food Safety Authority [Norw.: Mattilsynet] 
NNR  – Nordic Nutrition Recommendations 
NOAEL  – no observed adverse effect level 
NTP  – National Toxicology Program 
OECD  –  Organisation for Economic Co-operation and Development  
PARNUTS – foods for particular nutritional uses 
PRI  – population reference intakes 
RDA  – recommended dietary allowances 
RI  – recommended intake 
SCF  – Scientific Committee on Food 
SUL  – safe upper intake level 
TDI  – tolerable daily intake 
UF  – uncertainty factor 
UL  – tolerable upper intake level 
UB  – upper bound 
VKM  – Norwegian Scientific Committee for Food and Environment [Norw.: 
Vitenskapskomiteen for mat og miljø] 
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Glossary 
The margin of exposure (MOE) is the ratio of the NOAEL to the estimated exposure dose. 
P5, P25, P50, P75 or P95-exposure is the calculated exposure at the 5, 25, 50, 75 or 95-
percentile. 
Percentile is a term for visualising the low, medium and high occurrences of a 
measurement by splitting the whole distribution into one hundred equal parts. A percentile is 
a statistical measure indicating the value below which a given percentage of the observations 
fall. E.g. the 95-percentile is the value (or score) below which 95 percent of the observations 
are found. 
EFSA - Dietary Reference Values (DRVs) (EFSA, 2010b) 
Average Requirement (AR) is the level of intake of a defined group of individuals 
estimated to satisfy the physiological requirement of metabolic demand, as defined by a the 
specific criterion for adequacy for the nutrient, in half of the heathy individuals in a life stage 
or sex group, on the assumption that the supply of other nutrients and energy is adequate.   
If an AR cannot be determined than an Adequate Intake is used.   
Adequate Intake (AI) is defined as the average (median) daily level of intake based on 
observed, or experimentally determined approximations or estimates of a nutrient intake, by 
a group (or groups) of apparently healthy people, and therefore assumed to be adequate. 
The practical implication of an AI is similar to that of a population reference intake, i.e. to 
describe the level of intake that is considered adequate for health reasons. The 
terminological distinction relates to the different ways in which these values are derived and 
to the resultant difference in the "firmness" of the value.  
Population Reference Intake (PRI) is derived from AR of a defined group of individuals 
in an attempt to take into account the variation of requirements between individuals.  
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Figure 1: Population reference intake (PRI and average requirements (AR), if the requirement has a 
normal distribution and the inter-individual variation is known (EFSA, 2010b). 
Lower Threshold Intake (LTI) is the lowest estimate of requirement from the normal 
distribution curve, and is generally calculated on the basis of the AR minus twice its SD. This 
will meet the requirement of only 2.5% of the individuals in the population.  
 
Tolerable Upper intake Level (UL) is the maximum level of total chronic daily intake of a 
nutrient (from all sources) judged to be unlikely to pose a risk of adverse health effects to 
humans.  
 
Figure 2: Relationship between individual intake and risk of adverse effects due to insufficient or 
excessive intake. 
IOM - Dietary Reference Intakes (DRIs) (IOM, 2000) 
Estimated Average Requirement (EAR) is a nutrient intake value that is estimated to 
meet the requirement of half the healthy individuals in a life stage and gender group.  
Recommended Dietary Allowances (RDA) is the dietary intake level that is sufficient to 
meet the nutrient requirement of nearly all (97 to 98 percent) healthy individuals in a 
particular life stage and gender group. RDA = EAR + 2 SDEAR  or if insufficient data to 
calculate SD a factor of 1.2 is used to calculate RDA; RDA = 1.2*EAR 
Adequate Intake (AI) is the recommended intake value based on observed or 
experimentally determined approximations or estimates of nutrient intake by a group (or 
groups) of healthy people that are assumed to be adequate – used when an RDA cannot be 
determined 
Tolerable Upper Intake Level (UL) is the highest level of nutrient intake that is likely to 
pose no risk of adverse health effects for almost all individuals in the general population.  
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Figure 3: Dietary reference intakes. 
NNR -Recommended Intake (NNR Project Group, 2012) 
Average Requirement (AR) is defined as the lowest long-term intake level of a nutrient 
that will maintain a defined level of nutritional status in an individual i.e. the level of a 
nutrient that is sufficient to cover the requirement for half of a defined group of individuals 
provided that there is a normal distribution of the requirement.  
ARNNR = EARIOM = AREFSA 
Recommended Intake (RI) is defined as the amount of a nutrient that meets the known 
requirement and maintains good nutritional status among practically all healthy individuals in 
a particular life stage or gender group. RI= AR + 2SDAR.  
RINNR = RDAIOM = PRIEFSA 
Upper Intake Level (UL) is defined as the maximum level of long-term (months or years) 
daily nutrient intake that is unlikely to pose a risk of adverse health effects in humans.  
ULNNR =ULIOM = ULEFSA 
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Figure 4: Derivation of Upper Intake Level (UL)  
UF: Uncertainty factor 
Expert group on vitamins and minerals (EVM), UK (EVM, 2003) 
Safe Upper Intake Level (SUL): EVM used SUL instead of UL and defined SUL as the 
determination of doses of vitamins and minerals that potentially susceptible individuals could 
take daily on a life-long basis, without medical supervision in reasonable safety. The setting 
of these levels provided a framework within which the consumer could make an informed 
decision about intake, having confidence that harm should not ensue. The levels so set will 
therefore tend to be conservative. 
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Background as provided by the 
Norwegian Food Safety Authority 
Directive 2002/46/EC on food supplements was implemented into Norwegian law in 2004 in 
Regulation 20 May 2004 No. 755 on food supplements. Pursuant to Directive 2002/46/EC, 
common maximum and minimum levels of vitamins and minerals in food supplements shall 
be set in the EU. The European Commission started to establish common limits in 2006, but 
the work was temporarily put on standstill in 2009. The time frame for the further work is 
not known.  
National maximum limits for vitamins and minerals were established in the former vitamin 
and mineral supplements regulation from 1986 and were continued in the 2004 regulation.  
The national maximum and minimum limits in the food supplement regulation were 
established a long time before the food supplement directive was adopted, and the limits 
were consequently not established in accordance with the criteria for limits set in the food 
supplement directive. Maximum limits for vitamins and minerals which were not already 
revised according to the criteria in article 5 in the food supplement directive, were therefore 
repealed from 30 May 2017.  
Maximum limits for levels of vitamins and minerals in food supplements shall be set on basis 
of the following criteria, pursuant to article 5 in Directive 2002/46/EC:  
• Upper safe levels of vitamins and minerals established by scientific risk assessment 
based on generally accepted scientific data, taking into account, as appropriate, the 
varying degrees of sensitivity of different consumer groups  
• Intake of vitamins and minerals from other dietary sources  
When the maximum levels are set, due account should also be taken of reference intakes of 
vitamins and minerals for the population.  
Pending establishment of common maximums limits in the EU, the Norwegian Food Safety 
Authority is evaluating the national maximum limits for vitamins and minerals in food 
supplements.  
Norwegian authorities will as soon as possible, when it exists a scientific basis, and pending 
establishment of common maximums limits in the EU, establish new national maximum limits 
for those vitamins and minerals where limits were repealed 30 May 2017.  
Assessment of chromium  
The Norwegian Food Safety Authority will consider establishing a new national maximum 
limit for chromium in the food supplement regulation.  
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The former maximum limit for chromium was 125 μg per daily dose, but was repealed from 
30 May 2017. The minimum limit and permitted chromium substances that may be used in 
the manufacture of food supplements, are listed in annex 1 and annex 2 in the food 
supplement regulation.   
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Terms of reference as provided by the 
Norwegian Food Safety Authority 
The Norwegian Food Safety Authority (NFSA, Mattilsynet) requests the Norwegian Scientific 
Committee for Food and Environment (VKM) to assess the intake of chromium from the diet, 
including fortified products, in all age groups in the population above 1 year (mean intakes, 
median, P5, P95). 
As there is no data on chromium in the Norwegian food composition data base (KBS), VKM 
is requested to evaluate if other relevant intake data can be used - included the EFSA 
Scientific Opinion on Dietary reference values for chromium (2014). 
VKM is also requested to evaluate the consequences of establishing a maximum limit for 
chromium in food supplements of 50, 125, 200 or 300 μg per daily dose, and to evaluate 
these scenarios against existing tolerable upper intake levels.  
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Assessment chromium 
1 Introduction 
Chromium is ubiquitous, occurring in water, soil and biological systems. Also in the diet 
chromium is ubiquitous. Foods rich in chromium include meat and meat products, oils and 
fats, breads and cereals, fish, pulses and spices. 
Chromium has an atomic mass of 51.9961 Da and occurs in each of the oxidation states 
from -2 to +6, with +6 being the state most often studied. Chromium compounds with 
oxidation states below +3 are reducing, and above +3 are oxidising. Because of the high 
energy needed to oxidise the +3 form to the +6 form, oxidation does not occur in biological 
systems (EFSA, 2014a).  
Absorption of Cr(III) from food has been estimated to range from 0.4 to 2.5%, depending 
among other factors on the chemical properties of the ingested source and the presence of 
other dietary components. Absorption efficiency of supplemental Cr(III) has been reported to 
be between 0.1 and 5.2%, and to vary to a limited extent between the chromium complex 
ingested. Vitamin C has been reported to enhance the absorption of chromium in women 
(EFSA, 2014a).  
Absorbed Cr(III) binds to plasma proteins such as transferrin, and less than 5% is present in 
an unbound form. Chromium is then transported to the liver, and accumulates mainly in the 
liver and spleen, but can also be found in other soft tissues and bone. Urine is the main 
excretory route for chromium. Faecal chromium is mainly unabsorbed chromium. No markers 
of chromium body burden have been identified (EFSA, 2014a). 
Trivalent chromium has been reported to be an essential trace element in that it has been 
postulated to be necessary for the efficacy of insulin in regulation of the metabolism of 
carbohydrates, lipids and proteins. However, no mechanisms for these roles have been 
identified. The physico-chemical properties of Cr(III) do not support ligand exchange and 
transitions on oxidation states, as would be expected if Cr(III) were to be catalytic; rather it 
has been argued that Cr(III) influences the conformation of insulin and its interaction with its 
peripheral receptors. A circulating complex of Cr(III) and an oligopeptide of aspartate, 
glycine, cysteine and glutamate, named low-molecular weight Cr-binding substance or 
chromodulin (Chen et al., 2011) has been proposed as the means by which Cr(III) mediates 
responses to insulin. However, the Panel on Dietetic Products, Nutrition and Allergies (NDA 
Panel) in the European Food Safety Authority (EFSA) found that chromodulin’s existence and 
function is unclear as is the functional essentiality of Cr(III) (EFSA, 2014a). 
Quantification methods of chromium in food are discussed in EFSA (2014a)  and EFSA 
(2014b).  The Association of Analytical Communities (AOAC) Official Method 990.08 for 
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quantifying chromium in food and water does not discriminate between Cr(III) and Cr(VI). It 
should be noted that the reliability of chromium data for biological and food samples 
measured before 1980s has been questioned because of low sensitivity of the methods used 
as well as contamination issues. 
In general, Cr(III) has very low toxicity by the oral route (ATSDR, 2012), and there are 
hardly any well-documented observations of toxicity after peroral intake in humans. In a 
series of animal repeat dose toxicity studies, the no observed adverse effect level (NOAEL) 
for general toxicity was consistently the highest dose tested (EFSA, 2014b). There are some 
conflicting results regarding developmental and reproductive toxicity, with the lowest 
observed adverse effect levels (LOAELs in the order of 30 mg/kg bw per day when effects 
were observed. The extensive literature on genotoxicity of Cr(III) also provides some 
conflicting results, with largely negative results in bacterial assays and mixed results in 
mammalian cell assays. EFSA concluded that Cr(III) is not carcinogenic in experimental 
animals (EFSA, 2014b).  
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2 Recommendations and tolerable 
upper intake levels 
2.1 Recommendations 
There are no Norwegian recommendations for intake of chromium. The Nordic Nutrition 
Recommendations (2012) concluded that no recommendations could be given for chromium 
due to lack of sufficient evidence (NNR Project Group, 2012). 
In 2014, EFSA issued an opinion on Dietary Reference Values (DRVs) for chromium (EFSA, 
2014a). EFSA concluded that data are insufficient for deriving Average Requirements (ARs) 
or Population Reference Intakes (PRIs) for chromium. Furthermore, EFSA noted that there is 
no convincing evidence for a role of chromium in human metabolism and physiology, and no 
proof that chromium is an essential trace element, nor could chromium be linked to any 
beneficial health effects in healthy, normoglycaemic people. The EFSA NDA Panel therefore 
found that the setting of an Adequate Intake (AI) for chromium is not appropriate (EFSA, 
2014a). AIs for chromium were given in the report Dietary Reference Intakes from Institute 
of Medicine (IOM, 2001), USA. AI for adults were set to 25 µg/day for women and 35 µg/day 
for men.  
2.2 Tolerable upper intake levels 
World Health Organization (WHO, 1996) 
In a report of a re-evaluation of the role of trace elements in human health and nutrition, it 
is stated that  trivalent chromium has such a low toxicity that deleterious effects of excessive 
intake of this form of chromium do not readily occur, and that the relatively non-toxic nature 
of chromium as found in food indicates that the tolerable limit for chromium is quite high. 
Further, it is stated that “Findings that supplements of 125-200 µg of chromium/day, in 
addition to the usual dietary intake, can in some cases reverse hypoglycaemia and impaired 
glucose tolerance, and improve both circulating insulin levels and the lipid profile, suggest 
that the upper limit of the safe range of population mean intakes could be above 
250 µg/day”. However, until more is known about chromium, it was found appropriate that 
supplementation of this element should not exceed this amount. 
Institute of Medicine (IOM, 2001), USA 
It is stated that the limited studies on renal, hepatic, reproductive, and DNA damaging 
effects of chromium III do not provide dose-response information or clear indications of a 
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LOAEL or a NOAEL. Thus, there are insufficient data to establish a tolerable upper intake 
level (UL) for soluble chromium III salts.  
Expert Group on Vitamins and Minerals (EVM, 2003), UK 
It is said that overall, there are insufficient data from human or animal studies to derive a 
safe upper level for chromium, although the oral toxicity of poorly absorbed trivalent 
chromium appears to be low.  
The study by Anderson et al. (1997) was cited to indicate that 15 mg/kg bw/day chromium 
(as chromium chloride) was not associated with adverse effects in the rat. Based on this 
study, and allowing uncertainty factors of 10 for inter-species variation and 10 for inter-
individual variation, a total daily intake of about 0.15 mg/kg bw/day (or 10 mg/person/day) 
would be expected to be without adverse health effects. This value was said to be used for 
guidance purposes and applied to trivalent chromium only.  
Scientific Committee on Food (SCF, 2003) 
The Scientific Committee on Food (SCF) stated that data on the oral toxicity of trivalent 
chromium are limited. Doses up to 15 mg chromium/kg bw/day did not show adverse effects 
in a feeding study with chromium chloride and chromium picolinate in rats for 20 weeks 
(Anderson et al., 1997).  
In mice, doses of 250 to 1250 mg/kg body weight chromium chloride decreased fertility 
significantly and reduced body weights in males (Elbetieha and AlHamood, 1997).  
Human data on trivalent chromium were found to be limited. No adverse effects were 
reported in a number of supplementation trials, in which subjects received up to 1 mg 
chromium/day, mostly as picolinate for several months. These trials, however, were mainly 
studies of efficacy and not designed to find potential toxic effects.  
The limited data from studies on subchronic, chronic, and reproductive toxicity on soluble 
trivalent chromium salts and the available human data were found not to give clear 
information on the dose response relationship. Therefore, a tolerable upper intake level 
could not be derived.  
The US Institute of Medicine also concluded that the data from animal and human studies 
were insufficient to establish an UL for soluble chromium (III) salts (IOM, 2001).  
VKM mini-review (VKM, 2007), Norway 
VKM refers to a study on rats by Anderson et al. (1997) (see below), and a proposal by 
the UK Expert Group on Vitamins and Minerals (EVM, 2003). Based on this study, EVM had 
concluded that allowing for an uncertainty factor of 100, a dose of chromium of 
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0.15 mg/kg bw/day, or 9 mg in a 60 kg person, would be expected to be without 
adverse health effects. VKM then goes on citing a later study in rats by (Scibior and 
Zaporowska, 2007). In this study, 0.3 mg chromium/kg bw/day resulted in a significant 
decrease in kidney GSH (reduced glutathione) concentration and GSH/GSSG (oxidised 
glutathione) ratio in both liver and kidney, indicating that chromium has pro-oxidative 
effects. Based on the results from the GSH study, VKM found that it could not be ruled 
out that an intake of chromium much lower than 9 mg/day for adults proposed by EVM 
may represent a health risk. VKM therefore encouraged a more restrictive guidance level 
for chromium, and with the GSH study in mind stated that, for the time being, the 
guidance level for upper intake should be maximum 1 mg/day for an adult. 
European Food Safety Authority, ANS Panel (EFSA, 2010a and c) 
Safety of trivalent chromium as a added nutrient  
The EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS Panel) 
delivered a scientific opinion re-evaluating the safety of chromium(III) as a nutrient added to 
foods for particular nutritional uses (PARNUTS) and foods intended for the general 
population (including food supplements) (EFSA, 2010c). The background was the doubt 
raised in some studies about the safety of cromium(III)picolinate. The opinion therefore 
focused on cromium(III)picolinate in relation to the (then) current recommendations 
regarding Cr(III) intake, rather than on performing a full general re-evaluation of the levels 
of Cr(III) intake that should not be exceeded. Based on the facts i) that maximum intake 
levels of up to 250 µg/day for supplemental intake as suggested by the WHO (1996) would 
be in the same order of magnitude as the exposure resulting from normal dietary intake ii) 
that in vitro, at high concentrations, chromium(III) might cause DNA damage, iii) that this 
DNA damage is not reflected in in vivo genotoxicity assays performed according to standard 
Organisation for Economic Co-operation and Development (OECD) protocols and in National 
Toxicology Program (NTP) studies, iv) that chromium(III) is not carcinogenic, v) that there is 
a large margin of safety of 4 to 5 orders of magnitude between a daily intake of 
250 µg/day, equivalent to 4.1 µg/kg bw per day for a 60 kg person, and the NOAEL of 
300 mg/kg bw/day for chromium(III) calculated from the NOAEL for chromium(III) 
picolinate in the long-term NTP studies in mice and rats, the EFSA Panel concluded that the 
safety of chromium(III) as a nutrient added to PARNUTS and foods intended for the 
general population (including food supplements) is not of concern, provided that the intake 
of chromium(III) from these sources does not exceed 250 µg/day, the value established by 
the WHO (1996) for supplemental intake of chromium that should not be exceeded. 
Safety of chromium picolinate as a source of chromium  
This report was focused on the safety of picolinate, and the aim was not to re-evalute the 
general intake level of Cr(III) not to be exceeded. The EFSA ANS Panel concluded that the 
use of chromium(III) picolinate as a source of chromium added for nutritional purposes to 
PARNUTS and foods intended for the general population (fortified foods and food 
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supplements) would not be of concern provided that the amount of total chromium did 
not exceed 250 μg/day, the value established by the WHO (1996) for supplemental intake of 
chromium that should not be exceeded (EFSA, 2010a). 
European Food Safety Authority, (EFSA, 2014b) 
Risk related to public health related to the presence of chromium in food and 
drinking water  
The EFSA Panel in on Contaminants in the Food Chain (CONTAM Panel) derived a tolerable 
daily intake (TDI) of 0.3 mg/kg bw per day for Cr(III) from the lowest NOAEL identified in 
the extensive NTP chronic (2-year) oral toxicity study in mice and rats (EFSA, 2014b; NTP, 
2010). Under the assumption that all chromium in food is Cr(III), the mean and 95th 
percentile dietary exposure across all age groups in Europe were found to be well below the 
TDI and therefore does not raise concerns for public health. In the case of drinking water, 
the EFSA CONTAM Panel considered all chromium in water as Cr(VI). However, the CONTAM 
Panel noted that to improve the risk assessment, there is a need for data on the content of 
Cr(III) and Cr(VI) in food and drinking water. 
Nordic Nutrition Recommendations (NNR Project Group, 2012) 
It is stated: “Trivalent chromium has generally low toxicity, no adverse effects were 
observed [in the scientific literature] at intakes of 1,000–2,000 µg/d. Due to the lack of 
adequate data, the EU Scientific Committee on Food has not suggested a Tolerable Upper 
Intake Level (UL) for chromium (III) salts. The same conclusion was reached by the U.S. 
Food and Nutrition Board and the UK Expert Group on Vitamins and Minerals.”  
 Summary tolerable upper intake levels 
Table 2.2.1-1 Overview of suggestions for intake levels in adults not to be exceeded set by various 
authorities. 
Authority Intake levels 
not to be 
exceeded* 
 Based on NOAEL UF 
WHO, 1996 250 µg/day     
SCF, 2003 -  - - - 
IOM, 2001 -  - - - 
EVM, 2003  150 µg/kg 
bw/day (or 9000 
µg/60 kg 
person)  
 Anderson et 
al., 1997, in 
the rat 
15 mg/kg 
bw/day 
100 
VKM, 2007 1000 µg/day  Based on EVM, 
plus a newer 
publication 
 900 
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Authority Intake levels 
not to be 
exceeded* 
 Based on NOAEL UF 
EFSA, 2010c 250 µg/day  Follows WHO, 
1996 
300 mg/kg 
bw day NTP 
rat studies** 
Margin of 
safety 4-5 
orders of 
magnitude 
EFSA, 2010a 250 µg/day  Follows WHO, 
1996 
300 mg/kg 
bw/day NTP 
rat studies** 
 
NNR, 2012 -  - - - 
EFSA, 2014b TDI 300 µg/kg 
bw per day 
 NTP 2-year 
toxicity studies 
in rats  
300 mg/kg 
bw/day NTP 
rat studies 
1000 
*various suggestions for intake levels not to be exceeded, none of them an UL, see report summaries 
above. 
**referred to in the discussion of the safety of the recommendations of levels not to be exceeded, but 
not used as a basis for arriving at the suggestion of the 250 µg/day dose.  
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3 Chromium(III) intakes 
No Norwegian data on chromium intakes are available. The most recent and comprehensive 
data available on chromium(III) intake are found in the EFSA opinion on chromium in food 
and drinking water (EFSA, 2014b). This report gives mean and 95th percentile dietary 
exposure estimates (µg/kg bw per day) for Cr(III) in food and Cr(VI) in water calculated for 
each of 26 dietary surveys from 17 European countries, as well as summary estimates 
(median and 95th percentile).  
To obtain data on chromium levels in foods, EFSA published a call in which European 
national food authorities and similar bodies, research institutions, academia, feed and food 
business operators and any other stakeholders were invited to submit data. A total of 81 247 
analytical results on chromium were made available. About 80% of the samples reported had 
been collected in Germany. After Germany, Cyprus, Slovakia and Ireland were the countries 
where the highest number of samples had been collected. To secure an appropriate quality 
of the data used in the subsequent exposure assessment, the initial chromium concentration 
dataset was evaluated applying a number of data cleaning and validation steps (EFSA, 
2014b).  
The food consumption data were from the EFSA Comprehensive European Food 
Consumption Database (EFSA, 2011), based on data provided by EU member states and the 
food consumption data for children obtained through an EFSA Article 36 project (Huybrechts 
et al., 2011). For calculating the chronic dietary exposure to Cr(III), food consumption and 
body weight data at the individual level were accessed in the Comprehensive Database.  
The EFSA CONTAM Panel (EFSA, 2014b) noted that there is a lack of data on the presence of 
Cr(VI) in food, and decided to consider all the reported analytical results in food as Cr(III). 
This assumption was based on recent speciation work by Kovacs et al. (2007) and Novotnik 
et al. (2013), on the fact that food is overall a reducing medium that would likely cause 
Cr(VI) to be reduced to Cr(III), and that oxidation of Cr(III) to Cr(VI) would not be favoured 
in such a medium. In contrast, in drinking water chromium may easily be present in the 
hexavalent state, not only due to anthropogenic contamination events, but also because 
water treatment facilities use strong oxidants to make water potable. 
Thus, reported analytical results for total chromium in food were assumed to be as Cr(III), 
as it was  assumed that the Cr(VI) present in water, in food is completely reduced to Cr(III). 
These assumptions were also made for water-based foods (following the FoodEx 
classification) (EFSA, 2011) like ‘fruit and vegetable juices’, ‘soft drinks’ and ‘alcoholic 
beverages’. However, certain foods are prepared with water to be consumed (coffee, tea 
infusions, and dry infant and follow-on food), and an incomplete reduction of the Cr(VI) 
present in this water into Cr(III) may happen if the foods are ingested immediately after 
their preparation. In these cases, the occurrence data on Cr(III) reported for dry foods were 
used with appropriate dilution factors to estimate the exposure to Cr(III). For each country, 
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estimates of dietary exposure to Cr(III) were calculated per dietary survey and age class. 
Because different methodologies were used between surveys to collect data, direct country-
to-country comparisons can be misleading. Complete data for the surveys used and the 
results can be found in the EFSA CONTAM Panel 2014 opinion (EFSA, 2014b). The EFSA 
report also gives detailed data on the contribution of the different food categories to the 
chromium (III) intake in the various age groups. Lower-bound (LB) and upper-bound (UB)  
values were given for the population groups toddlers ( ≥ 12 months to ≤ 36 months old), 
other children (≥ 36 months to < 10 years old), adolescents (≥ 10 years to < 18 years old), 
adults (≥ 18 years to < 65 years old), elderly (≥ 65 years to < 75 years old) and very elderly 
(≥ 75 years old) (Table 3-1).  
Mean chronic dietary exposure values across age classes, countries and surveys, ranged 
from 0.6 µg/kg bw per day (minimum LB) to 5.9 µg/kg bw per day (maximum UB). The 95th 
percentile dietary exposure ranged from 1.1 µg/kg bw per day (minimum LB) to 9.4 µg/kg 
bw per day (maximum value UB). A tendency was observed for higher exposure values to be 
found for toddlers and other children compared to the older age groups. Median dietary 
chromium intake values were 80-300 times lower than the suggested tolerable daily intake 
(TDI) of 300 µg/kg bw per day (EFSA 2014b). 
Table 3-1 Summary statistics of the chronic exposure assessment (µg/kg bw per day) for Cr(III) 
across European dietary surveys. Estimates were rounded up to one decimal place. Source: EFSA, 
2014b. 
Age groups 
Mean dietary exposure (µg/kg bw per day) 
 Min LB Median LB Max LB Min UB Median UB Max UB 
Toddlers 2.3 2.4 4.6 3.1 3.7 5.9 
Other children 1.6 2.4 3.5 2.1 3.3 4.9 
Adolescents 0.9 1.2 2.1 1.2 1.6 2.5 
Adults 0.8 0.9 1.2 1.0 1.2 1.6 
Elderly 0.6 0.8 1.0 1.0 1.1 1.4 
Very elderly 0.7 0.8 1.2 1.0 1.1 1.5 
 95th percentile dietary exposure (µg/kg bw per day) 
 Min LB Median LB Max LB Min UB Median UB Max UB 
Toddlers 3.4 4.5 5.9 4.5 6.7 9.0 
Other children 2.9 4.2 7.3 3.7 5.6 7.9 
Adolescents 1.7 2.4 4.1 2.3 2.9 4.8 
Adults 1.2 1.5 2.0 1.7 2.0 2.6 
Elderly 1.1 1.3 1.5 1.6 1.7 2.0 
Very elderly 1.2 1.6 1.8 1.7 2.0 2.3 
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In absolute numbers, median dietary chromium intakes were 28.6-44.0 μg/day (medians of 
lower and upper bound) in toddlers, 55.4-76.2 μg/day in other children, 52.1-69.4 μg/day in 
adolescents (≥10 to <14 years), 73.6-98.1 in adolescents (≥14 to <18 years) and 63.0-
84.0 μg/day in adults (EFSA, 2014b) (adolescent values calculated from relative intake for 
age group 10-18 years).  
Due to the limited and incomplete consumption information in the Comprehensive Database 
on fortified foods, PARNUTS and food supplements was excluded from the dietary exposure 
calculations. Intakes from this food group were calculated separately by an approach used 
previously by the EFSA ANS Panel (EFSA, 2010a). Levels per serving equal to 12 µg of Cr(III) 
from fortified foods and 300 µg of chromium from PARNUTS had been proposed by the ANS 
Panel. No use levels were proposed for food supplements, but the EFSA ANS Panel noted 
that levels up to 600 µg/day Cr(III) could be consumed from supplements. Using these 
values, the typical exposure due to supplemental intake in the EFSA study would be about 10 
times higher than that obtained from food intake. One might possibly argue that for Norway, 
data from the Nordic countries would be more valid than data collected from all over Europe, 
because Norwegian dietary habits might be more similar to the other Nordic countries than 
to eating habits in Eastern and Southern European countries. However, comparing the data 
from the European dataset (Table 3-1)to the Nordic countries (Table 3-2), it is found that 
mean dietary exposure to Cr(III) across all the different European surveys shows a fairly 
similar range as the data from the Nordic surveys (0.6 to 5.9 µg/kg bw per day vs. 0.8 to 
3.7) (minimum LB to maximum UB). The largest difference between the Nordic countries 
dataset and the all-European dataset was seen for the maximum UB. Similarly, the 95th 
percentile dietary exposure data showed a similar range in the Nordic and the European 
datasets (1.1 to 9.0 µg/kg bw per day vs. 1.2 to 8.4) (minimum LB to maximum UB) (Table 
3-2). 
Table 3-2 Mean and 95th percentile (P95) chronic dietary exposure to Cr(III) (μg/kg bw per 
day) for population groups in lower-bound (LB) and upper-bound (UB) scenario in the Nordic 
countries (data from EFSA, 2014b)*. 
DK: Denmark; FI: Finland SE: Sweden. 
*Data for elderly and very elderly not included. 
In conclusion, VKM will base its evaluation upon the larger European dataset generated by 
the EFSA CONTAM Panel, which is likely to be valid also for Norway. 
 Toddlers Other children Adolescents Adults 
 Mean P95 Mean P95 Mean P95 Mean P95 
DK - - 1.87-2.79 2.92-4.24 1.01-1.53 1.71-2.53 0.78-1.13 1.22-1.75 
FI/1 2.37-3.70 5.07-8.44 2.35-3.57 4.20-5.99 - - - - 
FI/2 - - - - - - 0.77-1.15 1.37-2.02 
FI/3 - 2.22-3.02 3.72-4.61 - - - - - 
SE/1 - - - - - - 1.00-1.33 1.68-2.18 
SE/2 - - 2.47-3.37 5.33-6.32 1.62-2.11 3.33-3.99 - - 
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4 Assessment of the intakes of 
chromium 
4.1 Evaluation of chromium intakes, including scenarios with 
supplementation  
Toxicity of trivalent chromium and establishment of a TDI for Cr(III) 
The EFSA CONTAM Panel (EFSA, 2014b) established a TDI of 300 µg/kg bw per day for 
Cr(III) based on the NOAEL determined in a 2-year US National Toxicology Program study in 
rats (NTP, 2010) where no adverse effects were observed even at the highest dose tested. 
Due to the uncertainty in the available data on developmental and reproduction toxicity, the 
EFSA CONTAM Panel applied an uncertainty factor of 10 in addition to the default uncertainty 
factor of 100 for the extrapolations from rodents to humans and for human variability. 
Evaluation – risk characterisation 
Under the assumption that all chromium in food is Cr(III) and all chromium in water Cr(IV), 
the mean dietary exposure to Cr(III) across all age groups and surveys (minimum LB of 
0.6 μg/kg bw per day and maximum UB of 5.9 μg/kg bw per day) as well as the 95th 
percentile exposure (minimum LB of 1.1 μg/kg bw per day and maximum UB of 9.0 μg/kg 
bw per day) are below the TDI by a factor of more than 10. The CONTAM Panel concluded 
that the current dietary exposure to Cr(III) does not raise concern from a public health point 
of view. 
Regarding the vegetarian population, although based on limited consumption data, the 
dietary exposure to Cr(III) was found by the EFSA CONTAM Panel to be similar to that 
estimated for the general population. The CONTAM Panel concluded that the dietary 
exposure of vegetarians is well below the TDI of 300 μg Cr(III)/ kg bw per day. 
Exposure scenarios 
VKM was requested to conduct scenario estimations to illustrate the consequences of 
amending maximum limits for chromium to 50, 125, 200 or 300 µg/day in food supplements. 
The results are shown in Table 4.1-1 and 4.1-2 (without possible contribution from fortified 
foods and PARNUTS). Even with the highest level of supplemental intake, median intake 
levels as well as the 95th percentile intake will be less than one tenth of the TDI of 
300 µg/kg bw per day, except for toddlers where the 95th percentile intake for UB plus 
300 µg supplementation will be nine times lower than the TDI. A daily serving of Cr(III)-
fortified food estimated at 12 µg Cr(III) (see Section 3) will not change this.   
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Table 4.1-1 Mean exposure to Cr(III)(µg per day) from the diet and with different additional 
intake scenarios from supplements*. 
*LB = Lower bound, UB = Upper bound 
**EFSA default weight for toddlers 11.9 kg; other children 23.1 kg; adolescents 10 to <14 years, 43.4 
kg; adolescents 14 to <18 years 61,3 kg; adults, elderly and very elderly 70 kg. TDI 300 µg/kg bw per 
day.  
*** Cr(III) diet intake values based on relative intake for age group 10 to <18 years. 
 
Table 4.1-2 P95 exposure to Cr(III)(µg per day)from the diet and with different additional intake 
scenarios from supplements*. 
 Median 
LB 
Median 
UB 
LB+ 
50 
UB+ 
50 
LB+ 
125 
UB+ 
125 
LB+ 
200 
UB+ 
200 
LB+ 
300 
UB+ 
300 
TDI 
** 
Toddlers 
1-3 years 
53.6 79.7 103.6 129.4 178.6 204.4 253.6 279.4 353.6 379.4 3600 
Other children 
3-10 years 
97.0 129.4 147.0 179.4 222.0 254.4 297.0 329.4 397.0 429.4 6900 
Adolescents 
10-14 years 
104.2 125.9 154.2 175.9 229.2 250.9 304.2 325.9 404.2 425.9 113000 
Adolescents 
14-18 years 
147.1 177.8 197.1 227.8 272.1 302.8 347.1 377.8 447.1 477.8 18400  
Adults 
18-65 years 
105.0 140.0 155.0 190.0 230.0 265.0 305.0 340.0 405.0 440.0 21000 
Elderly 
65-75 years 
91.0 119.0 141.0 169.0 216.0 244.0 291.0 319.0 391.0 419.0 21000 
Very elderly 
≥ 75 years 
112.0 140.0 162.0 190.0 237.0 265.0 312.0 340.0 412.0 440.0 21000 
*LB = Lower bound. UB = Upper bound 
**EFSA default weight for toddlers 11.9 kg; other children 23.1 kg; adolescents - 10 to <14 years, 
adolescents 14 to <18 years 61,3 kg; 43.4 kg; adults, elderly and very elderly 70 kg. TDI 300 µg/kg 
bw per day. Cr(III) values based on relative intake for age group 10 to <18 years.  
 Median 
LB 
Median 
UB 
LB+ 
50 
UB+ 
50 
LB+ 
125 
UB+ 
125 
LB+ 
200 
UB+ 
200 
LB+ 
300 
UB+ 
300 
TDI** 
(µg) 
Toddlers 
1-3 years 
28.6  44.0 78.6 94.0 153.6 169.0 228.6 244.0 328.6 344.0 3600 
Other 
children 
3-10 years 
55.4 85.5 105.4 135.5 180.4 210.5 255.4 285.5 355.4 385.5 6900 
Adolescents 
10-14 
years*** 
52.1 69.4 102.1 119.4 177.1 194.4 252.1 269.4 352.1 369.4 13000  
Adolescents 
14-18 
years*** 
73.6 98.1 123.6 148.1 198.6 223.1 273.6 298,1 373.6 398.1 118400 
Adults 
18-65 years 
63.0 84.0 113.0 134.0 188.0 209.0 263.0 284.0 363.0 384.0 21000  
Elderly 
65-75 years 
56.0 77.0 106.0  127.0 181.0 202.0 256.0 277.0 356.0 377.0 21000  
Very elderly 
 ≥ 75 years 
56.0  77.0 106.0 127.0 181.0 202.2 256.0 277.0 356.0 377.0 21000  
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5 Uncertainties 
Uncertainty regarding how well the European food consumption studies and analytical data 
used by EFSA (2014b) reflect the true European average.  
Uncertainty regarding how well the European food consumption studies used by EFSA 
(2014b) reflect food consumption in Norway. 
Uncertainty whether there are subpopulations in Norway e.g. ethnic minorities that deviate 
strongly from the average Norwegian (and European) population with regard to dietary 
habits. 
Uncertainty regarding how well chromium level analyses of foods used by EFSA (2014b) 
represent chromium levels in foods consumed in Norway – there is an uncertainty about 
regional differences in chromium content in foods. 
Uncertainty due to the lack of appropriate consumption data for fortified foods, foodstuffs for 
particular nutritional use (PARNUTS) and food supplements. 
Uncertainty about the adequacy of the extra uncertainty factor of 10 added due to the 
uncertainty about developmental and reproduction toxicity. 
Uncertainty because the NOAEL was the highest dose tested. 
Due to the large proportion of left-censored data, LB values reported will tend to 
underestimate, and UB levels will tend to overestimate dietary exposure. 
Uncertainty about the contribution of stainless steel containers, processors and utensils to 
Cr(III) levels in foods as consumed – data on foods as consumed are virtually absent from 
the dataset used by EFSA. 
Uncertainties about the assumption that all Cr in foods is Cr(III) and all Cr in water is Cr(VI), 
and the content of Cr(III) (and Cr(VI)) in water-based foods and drinks. 
Uncertaity because of the absence of human studies on possible long-term adverse effects of 
chronic high Cr(III) intake. 
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6 Answers to the terms of reference 
The Norwegian Food Safety Authority (NFSA, Mattilsynet) has requested the Norwegian 
Scientific Committee for Food and Environment (VKM) to assess the intake of chromium from 
the diet, including fortified products, in all age groups in the population above age 1 year. 
EFSA has published summary as well as individual study estimates for Cr(III) intakes based 
on 26 dietary surveys from 17 European countries and analytical data on Cr(III) (EFSA, 
2014a). There were six Nordic studies included; from Denmark (1 study), Sweden (2 studies) 
and Finland (3 studies), but none from Norway. VKM considers that the summary data from 
this European study are valid also for Norway. Intake data (median lower and upper bound 
with max and min values) as well as the corresponding P95 data for the relevant standard 
EFSA age groups are given in Table 3-1.  
VKM is also requested to conduct scenario estimations to illustrate the consequences of 
establishing maximum limits for chromium to 50, 125, 200 or 300 µg/day. The outcomes are 
given in 4.1-1 (median (of individual study means) exposure lower and upper bound) and 
4.1-2 (95th percentile exposure levels). Even with the highest level of supplemental intake, 
median intake levels as well as the 95th percentile intake will be less than one tenth of the 
TDI of 300 µg/kg bw per day (except for toddlers where the 95th percentile intake for UB 
plus 300 µg supplementation will be about nine times lower than the TDI). This conclusion is 
not changed even if a daily serving of Cr(III)- fortified foods estimated at 12 µg Cr(III) as 
discussed under Section 3 is added. 
VKM emphasises that the current assessment of maximum limits for Cr(III) in food 
supplements is merely based on published reports concerning upper levels from the WHO 
(1996), IOM (2001, USA), SCF (2003, EU), EVM (2003, UK) , NNR (2012, Nordic countries), 
and EFSA (2014b). VKM has not conducted any systematic review of the literature for the 
current opinion, as this was outside the scope of the terms of reference from NFSA. 
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7 Data gaps 
• Data on Cr(III) levels in foods consumed in Norway 
• Dietary information for some population subgroups, e.g. ethnic minorities 
• Appropriate consumption data for fortified foods, foodstuffs for particular nutritional use 
(PARNUTS) and food supplements 
• More reliable data on developmental and reproduction toxicity 
• Identification of a LOAEL, because the NOAEL that was basis for the TDI was the highest 
dose tested 
• Quantitative data below the present limit of quantification 
• Data about the contribution of stainless steel containers, processors and utensils to 
Cr(III) levels in foods as consumed  
• Human studies on possible long-term adverse effects of chronic high Cr(III) intake 
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